Crimson Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 31-10-2024
- Paid Up Capital ₹ 0.80 M
as on 31-10-2024
- Company Age 34 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.27 Cr
as on 31-10-2024
- Revenue 8.78%
(FY 2023)
- Profit -15.78%
(FY 2023)
- Ebitda -387.18%
(FY 2023)
- Net Worth 3.21%
(FY 2023)
- Total Assets 6.29%
(FY 2023)
About Crimson Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹1.27 Cr.
Abhishek Jain, Yashvardhan Jain, Ravi Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MP1990PTC005795
- Company No.
005795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location.Gwalior, Madhya Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Crimson Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Jain  | Additional Director | 28-Apr-2017 | Current |
| Abhishek Jain | Director | 01-Jan-2007 | Current |
| Yashvardhan Jain | Director | 26-Apr-1990 | Current |
| Ravi Sharma | Director | 26-Apr-1990 | Current |
Financial Performance of Crimson Laboratories.
Crimson Laboratories Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 8.78% increase. The company also saw a substantial fall in profitability, with a 15.78% decrease in profit. The company's net worth moved up by a moderate rise of 3.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crimson Laboratories?
Unlock access to Crimson Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Aug 2021 | ₹5.00 M | Open |
Others Creation Date: 26 Jul 2017 | ₹4.00 M | Open |
Nagrik Sahakari Bank Maryadit Creation Date: 04 Apr 2001 | ₹2.50 M | Open |
How Many Employees Work at Crimson Laboratories?
Crimson Laboratories has a workforce of 2 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crimson Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crimson Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
